CD137 (known as 4-1BB), which is highly expressed in human atherosclerosis, promotes development of plaque inflammation [26], and its deficiency results in reduced atherosclerosis induced by hypercholesterolemia [27]. This evidence concerns the gene TNFRSF9 and atherosclerosis.